Does Quality of Life and Sexual Quality of Life in HIV Patients Differ Between Non-treated HIV Controllers and Treated Patients in the French ANRS VESPA 2 National Survey?


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 4 8 2018
medline: 19 3 2019
entrez: 4 8 2018
Statut: ppublish

Résumé

People living with HIV who spontaneously control the virus without antiretroviral treatment are called HIV Controllers and their status places them at the limits of bio-clinical normality. The objective of this study was to investigate an unexplored field: HIV Controllers' quality of life (QOL). Using quantitative methods, we compared the QOL of untreated (by definition) HIV Controllers in the ANRS CO18 HIV Controller cohort study, with the QOL of treated patients in the French national survey ANRS VESPA 2. In particular, the physical, social, mental and sexual dimensions of QOL were examined. Results highlight that perceiving oneself to be ill or healthy is linked to stigma and to a lack of self-identification with a social group. Some components of the QOL were significantly impaired in HIV controllers. This study is the first to investigate this field.

Identifiants

pubmed: 30073634
doi: 10.1007/s10461-018-2237-8
pii: 10.1007/s10461-018-2237-8
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-139

Auteurs

Marie Préau (M)

Social Psychology Research Group (EA 4163 GRePS), Lyon 2 University, Lyon University, Lyon, France. marie.preau@univ-lyon2.fr.
INSERM U912, Marseille, France. marie.preau@univ-lyon2.fr.

Marion Mora (M)

INSERM U912, Marseille, France.
Aix-Marseille University, UMR_S912, IRD, Marseille, France.
ORS PACA, Marseille, France.

Costanza Puppo (C)

Social Psychology Research Group (EA 4163 GRePS), Lyon 2 University, Lyon University, Lyon, France.

Vanessa Laguette (V)

CRP-CO (EA 7273), Picardie Jules Verne University, Amiens, France.

Luis Sagaon-Teyssier (L)

INSERM U912, Marseille, France.
Aix-Marseille University, UMR_S912, IRD, Marseille, France.
ORS PACA, Marseille, France.

Faroudy Boufassa (F)

Inserm U1018, CESP Centre for Research in Epidemiology and Population Health, Epidemiology of HIV and STI Team, Le Kremlin-Bicetre, France.

Laurence Meyer (L)

INSERM SC10 US19, Villejuif, France.

Olivier Lambotte (O)

Univ Paris Sud, UMR 1184, 94276, Le Kremlin-Bicêtre, France.
CEA, DSV/iMETI, IDMIT, 92265, Fontenay-Aux-Roses, France.
INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, 94276, Le Kremlin-Bicêtre, France.
Assistance Publique Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, 94275, Le Kremlin-Bicêtre, France.

Bruno Spire (B)

INSERM U912, Marseille, France.
Aix-Marseille University, UMR_S912, IRD, Marseille, France.
ORS PACA, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH